Intensity Therapeutics, Inc. Common stock — Institutional Ownership
Which tracked institutions hold INTS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
3
Funds holding
$258
Total value held
Buying
2 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Barclays Plc | $172 | 42 | +42 | NEW BUY |
| 2 | Morgan Stanley | $82 | 20 | — | Held |
| 3 | Ubs Group Ag | $4 | 1 | +1 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.